Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

17.75USD
23 Feb 2018
Change (% chg)

$0.15 (+0.85%)
Prev Close
$17.60
Open
$17.70
Day's High
$17.80
Day's Low
$17.15
Volume
70,007
Avg. Vol
73,841
52-wk High
$17.98
52-wk Low
$6.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.30 -0.684
Jun '17 0.30 -0.660
Mar '17 0.30 -0.668
FY 2016 Dec '16 0.30 -0.560
Sep '16 0.30 -0.557
Jun '16 0.24 -0.524
Mar '16 0.21 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 18.10 32.50 0.00 13.73
Earnings (per share)
Quarter Ending Mar-18 4 -0.61 -0.56 -0.68 --
Quarter Ending Jun-18 4 -0.58 -0.54 -0.62 --
Year Ending Dec-18 4 -1.76 -1.08 -2.28 -1.67
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. -- 285.81 46.17
P/E Low - Last 5 Yrs. -- 93.64 24.19
Beta -0.09 0.81 0.81
Price to Sales (TTM) 429.40 137.83 8.35
Price to Book (MRQ) 6.77 20.52 5.22
Price to Tangible Book (MRQ) 7.71 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions 52.09 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.00 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago 26.38 58.16 7.57
Sales - 5 Yr. Growth Rate -- 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -22.96 -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago -18.47 -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate -- 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 4.57 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.21 12.39
Total Debt to Equity (MRQ) 0.00 18.27 15.84
Interest Coverage (TTM) -- -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -4,738.06 -- --
EBITD - 5 Yr. Avg -6,446.46 -230.69 14.70
Operating Margin (TTM) -4,738.38 -487.70 4.10
Operating Margin - 5 Yr. Avg. -6,468.54 -247.29 9.99
Pre-Tax Margin (TTM) -4,682.52 -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -6,417.04 -253.91 10.24
Net Profit Margin (TTM) -4,683.38 -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -6,415.84 -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,297 23,863,557 817,554,851
Net Income/Employee (TTM) -1,934,076 -520,338 95,586,843
Receivable Turnover (TTM) 13.58 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.02 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -71.95 -1.04 10.73
Return on Assets - 5 Yr. Avg. -47.10 -0.14 12.03
Return on Investment (TTM) -84.77 -0.71 13.63
Return on Investment - 5 Yr. Avg. -52.69 2.18 15.76
Return on Equity (TTM) -84.95 -3.37 15.39
Return on Equity - 5 Yr. Avg. -53.70 -1.91 17.03
  1 Year 3 Year 5 Year
Sales % 59.19 144.78 --
EPS (TTM) % 0.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Stemline Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.09%
# of Holders: 115
Total Shares Held: 15,091,902
3 Mo. Net Change: 2,043,846
# New Positions: 14
# Closed Positions: 14
# Increased Positions: 50
# Reduced Positions: 44
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.